BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23578464)

  • 1. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
    Rizzo LY; Theek B; Storm G; Kiessling F; Lammers T
    Curr Opin Biotechnol; 2013 Dec; 24(6):1159-66. PubMed ID: 23578464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS; Leong DT; Mei L; Feng SS
    Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of nanoparticles for diagnosis and therapy of cancer.
    Baetke SC; Lammers T; Kiessling F
    Br J Radiol; 2015 Oct; 88(1054):20150207. PubMed ID: 25969868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting.
    Kunjachan S; Jayapaul J; Mertens ME; Storm G; Kiessling F; Lammers T
    Curr Pharm Biotechnol; 2012 Mar; 13(4):609-22. PubMed ID: 22214503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanotheranostics for personalized cancer therapy.
    Diou O; Tsapis N; Fattal E
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1475-87. PubMed ID: 23092183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotheranostics for personalized medicine.
    Mura S; Couvreur P
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
    Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
    Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
    Muthu MS; Mei L; Feng SS
    Nanomedicine (Lond); 2014 Jul; 9(9):1277-80. PubMed ID: 25204816
    [No Abstract]   [Full Text] [Related]  

  • 11. Materializing Personalized Medicine.
    Artzi N
    Adv Mater; 2020 Apr; 32(13):e1908065. PubMed ID: 32237118
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanomedicine platforms for cancer therapy.
    Zhang H
    J Nanosci Nanotechnol; 2012 May; 12(5):4012-8. PubMed ID: 22852341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
    Rehan F; Zhang M; Fang J; Greish K
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 19. Ligand-Installed Nanocarriers toward Precision Therapy.
    Mi P; Cabral H; Kataoka K
    Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon nanomaterials as versatile platforms for theranostic applications.
    Kim M; Jang J; Cha C
    Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.